CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Conditions: Lymphoma; Leukemia
Interventions: Drug: CMC-544; Drug: Fludarabine; Drug: Bendamustine; Drug: Rituximab; Procedure: Allogeneic Stem Cell Transplantation; Drug: Thymoglobulin; Drug: Tacrolimus; Drug: Methotrexate; Drug: G-CSF
Sponsors: M.D. Anderson Cancer Center; Pfizer
Recruiting - verified December 2016
Interventions: Drug: CMC-544; Drug: Fludarabine; Drug: Bendamustine; Drug: Rituximab; Procedure: Allogeneic Stem Cell Transplantation; Drug: Thymoglobulin; Drug: Tacrolimus; Drug: Methotrexate; Drug: G-CSF
Sponsors: M.D. Anderson Cancer Center; Pfizer
Recruiting - verified December 2016